Moreover, immunohistochemistry assay showed that the tumors treated with agomiR-152 plus cisplatin displayed a decreased proliferation percentage of Ki-67 positive tumor cells compared with the control group (Fig. 5g). The gene discussed is MKI67; the disease is neoplasm.